Argenica partners with Oxford spinoff for stroke evaluation

Perth-based Argenica Therapeutics has partnered with the University of Oxford’s artificial intelligence arm to evaluate the effectiveness of its flagship ARG-007 stroke drug and find previously hidden effects.